On November 20, 2023, ReShape Lifesciences Inc. (NASDAQ: RSLS) opened at $0.2451, lower -4.12% from the last session. During the day, the shares moved up to $0.25 and dropped to $0.2284 before settling in for the closing price of $0.24. Price fluctuations for RSLS have ranged from $0.19 to $22.40 over the past 52 weeks.
Top 5 EV Tech Stocks to Buy for 2023
The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".
Click Here to Download the FREE Report.
Sponsored
It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 35.05%. With a float of $12.94 million, this company’s outstanding shares have now reached $13.14 million.
The extent of productivity of a business whose workforce counts for 40 workers is very important to gauge. In terms of profitability, gross margin is +60.52, operating margin of -240.91, and the pretax margin is -414.54.
ReShape Lifesciences Inc. (RSLS) Insider and Institutional Ownership
A key investor’s attitude towards the stock of the Medical Devices industry is another important factor to consider. The insider ownership of ReShape Lifesciences Inc. is 1.47%, while institutional ownership is 3.13%. The most recent insider transaction that took place on Oct 25, was worth 35. In this transaction Chief Financial Officer of this company sold 131 shares at a rate of $0.27, taking the stock ownership to the 22,949 shares. Before that another transaction happened on Oct 11, when Company’s Chief Financial Officer sold 39 for $0.93, making the entire transaction worth $36. This insider now owns 23,080 shares in total.
ReShape Lifesciences Inc. (RSLS) Latest Financial update
If we go through the results of last quarter, which was made public on 9/29/2023, the company posted -$0.8 earnings per share (EPS) for the quarter, besting the agreed prediction (set at -$1.2) by $0.4. This company achieved a net margin of -411.16 while generating a return on equity of -185.85. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.79 per share during the current fiscal year.
ReShape Lifesciences Inc. (NASDAQ: RSLS) Trading Performance Indicators
Check out the current performance indicators for ReShape Lifesciences Inc. (RSLS). In the past quarter, the stock posted a quick ratio of 0.94. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.31.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -39.12, a number that is poised to hit -1.62 in the next quarter
Technical Analysis of ReShape Lifesciences Inc. (RSLS)
The latest stats from [ReShape Lifesciences Inc., RSLS] show that its last 5-days average volume of 0.5 million was inferior to 1.28 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 39.76%. Additionally, its Average True Range was 0.04.
During the past 100 days, ReShape Lifesciences Inc.’s (RSLS) raw stochastic average was set at 3.02%, which indicates a significant decrease from 20.04% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 72.07% in the past 14 days, which was lower than the 107.47% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.3651, while its 200-day Moving Average is $1.9181. Now, the first resistance to watch is $0.2439. This is followed by the second major resistance level at $0.2578. The third major resistance level sits at $0.2655. If the price goes on to break the first support level at $0.2223, it is likely to go to the next support level at $0.2146. The third support level lies at $0.2007 if the price breaches the second support level.
ReShape Lifesciences Inc. (NASDAQ: RSLS) Key Stats
There are currently 13,135K shares outstanding in the company with a market cap of 3.02 million. Presently, the company’s annual sales total 11,240 K according to its annual income of -46,210 K. Last quarter, the company’s sales amounted to 2,160 K and its income totaled -3,530 K.